| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
ANN ARBOR, Mich.—One of the problems of most prediction programs is that the algorithm is only as good as the training set upon which it was built. In looking at pharmacokinetics, researchers at the University of Michigan addressed by focusing their efforts on a program that operated from the cell's perspective.
 
As described in Molecular Pharmaceutics, the researchers used fundamental biophysical properties of cell membranes, cytoplasms, and compartments to develop a simulator that could predict passive transcellular permeability of small molecules. They then relied on three basic properties of druglike small molecules as determinants of transport and accumulation: the lipid/water partition coefficient of a neutral (logPn) and ionized (logPd) molecule and the dissociation constant of the protonated functional group (pKa).
 
Using tools like MATLAB and SRC PhysProp Database, the researchers predicted the permeability properties of a number of well characterized drugs and druglike small molecules, comparing the predicted results with the literature results. They noted a good correlation between the predicted values and those identified in PAMPA or Caco-2 assays, but even better correlation with human intestinal permeability results, where available.
 
The researchers acknowledge that their simulator only accommodates drugs distributed in high concentration via passive permeability, but argue that this represents the majority of existing drugs. They are looking to expand their model system to accommodate a wider spectrum of compounds.

About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A black mosquito is shown on pink human skin against a blurred green backdrop.

Discovering deeper insights into malaria research

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Three burgundy round and linear conformations of oligonucleotides are shown against a black background.

Accelerating RNA therapeutic testing with liver microphysiological platforms

Researchers can now study oligonucleotide delivery and efficacy in a system that models a real human liver.
A 3D-rendered illustration of a eukaryotic cell highlighting organelles such as the nucleus, endoplasmic reticulum, mitochondria, and cytoskeletal structures in pink and purple tones.

Shining light on the subcellular proteome

Discover how innovative proteomics tools help researchers peer into once inaccessible organelles, allowing for new targets for drug discovery and development.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue